- June 9, 2023
- EU Commission
European Union Proposes Amendments to Cosmetics Regulation to Address Endocrine Disruptors
The European Union is taking steps to amend Regulation (EC) No 1223/2009 concerning the use of Vitamin A, Alpha-Arbutin, and Arbutin, as well as substances with potential endocrine disrupting properties in cosmetic products.
This initiative is part of the ongoing efforts to adapt and update the Annexes to the Cosmetics Regulation. Based on scientific opinions from the Scientific Committee on Consumer Safety (SCCS), the proposed measures aim to regulate various substances used in cosmetic products.
The draft Commission Regulation includes the following provisions:
- Prohibition of 4-MBC: The UV-filter 4-MBC will be delisted from Annex VI and added to Annex II of the Cosmetics Regulation.
- Restrictions on Genistein, Daidzein, and Kojic Acid: These substances, used for skin conditioning, protecting, and lightening purposes in cosmetics, will be subject to restrictions outlined in Annex III.
- Further Restrictions on Triclosan and Triclocarban: The use of the preservatives Triclosan and Triclocarban in cosmetic products will be more tightly regulated by amending the existing restrictions in Annex V.
- Restrictions on Vitamin A Compounds: The Vitamin A compounds Retinol, Retinyl Acetate, and Retinyl Palmitate, commonly used as skin conditioning agents, will face restrictions detailed in Annex III.
- Restrictions on Alpha-Arbutin and Arbutin: These substances, utilized for skin bleaching and conditioning purposes, will be subject to limitations defined in Annex III.
More info and document available on chemycal.com